retatrutide weight loss study results 28.7% in New – Dr Brad Stanfield Retatrutide Results After 40: Realistic

Retatrutide is a synthetic 39-amino acid peptide classified as a triple agonist targeting GLP-1, GIP, and glucagon receptors

The approach depends on how many days have elapsed since the scheduled injection

doi: 10.3233/JAD-2012-129028 41 CalsolaroVEdisonP

The first readout, TRIUMPH-1 (obesity), was reported on 21 May 2026, with 28.3% mean weight loss at 80 weeks in the 12mg cohort (Pharmaceutical Journal)

Short Product Description The Synedica Retatrutide 40mg Injection Pen Kit is a precision-dosed peptide system delivering up to 40mg of Retatrutide in a convenient pen format, designed for controlled dosing, appetite suppression, and metabolic research applications

L.et al